Man Group PLC Kezar Life Sciences, Inc. Transaction History

Man Group PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$2.31 - $3.06 $39,501 - $52,326	17,100 Added 94.48%	35,200 $86,000
Q1 2023 May 15, 2023	BUY	$3.13 - $7.31 $56,653 - $132,311	18,100 New	18,100 $56,000
Q1 2021 May 17, 2021	SELL	$5.24 - $6.99 $64,452 - $85,977	-12,300 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$4.77 - $6.58 $58,670 - $80,934	12,300 New	12,300 $64,000

38.4M

13.8K

600

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $430M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.